Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Moodys
Federal Trade Commission
Deloitte
Healthtrust
Daiichi Sankyo
US Army
McKinsey
Novartis
Johnson and Johnson

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018181

« Back to Dashboard

NDA 018181 describes MYCELEX, which is a drug marketed by Bayer Healthcare Llc, Bayer Hlthcare, and Bayer Pharms, and is included in seven NDAs. Additional details are available on the MYCELEX profile page.

The generic ingredient in MYCELEX is clotrimazole. There are eleven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
Summary for 018181
Tradename:MYCELEX
Applicant:Bayer Hlthcare
Ingredient:clotrimazole
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018181

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;TOPICALStrength1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Expired US Patents for NDA 018181

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare MYCELEX clotrimazole SOLUTION;TOPICAL 018181-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Bayer Hlthcare MYCELEX clotrimazole SOLUTION;TOPICAL 018181-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Bayer Hlthcare MYCELEX clotrimazole SOLUTION;TOPICAL 018181-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Federal Trade Commission
Queensland Health
AstraZeneca
McKinsey
Covington
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot